Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Reducing the risk of contracting COVID-19 in patients with NSCLC (DE)

Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim

Reducing the risk of contracting COVID-19 in patients with NSCLC (DE) ( Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim )

Reducing the risk of contracting COVID-19 in patients with NSCLC (FR)

Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim

Reducing the risk of contracting COVID-19 in patients with NSCLC (FR) ( Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim )

Reducing the risk of contracting COVID-19 in patients with NSCLC (ES)

Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim

Reducing the risk of contracting COVID-19 in patients with NSCLC (ES) ( Dr Giuseppe Giaccone, Dr Neal Navani, Professor Eric Lim )

Promise of personalised medicine for patients with prostate cancer

Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt...

Promise of personalised medicine for patients with prostate cancer ( Prof Eleni Efstathiou, Prof Alicia Morgans, Prof Karim Fizazi and Prof Gerhardt Attard )

Cabozantinib most effective treatment for metastatic papillary kidney cancer

Dr Sumanta Pal - City of Hope, Duarte, USA

Cabozantinib most effective treatment for metastatic papillary kidney cancer ( Dr Sumanta Pal - City of Hope, Duarte, USA )

Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell...

Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology...

Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma ( Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, Nashville, USA )

New tools that can be used in clinical practice to make better decisions for...

Prof Martine Piccart - Université Libre de Bruxelles, Brussels, Belgium

New tools that can be used in clinical practice to make better decisions for women with early breast cancer ( Prof Martine Piccart - Université Libre de Bruxelles, Brussels, Belgium )

SEMS trial: result of a prospective, multi-institutional phase II clinical...

Dr Sia Daneshmand - University of Southern California, Los Angeles, USA

SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma ( Dr Sia Daneshmand - University of Southern California, Los Angeles, USA )

Sequencing endocrine treatment in metastatic luminal breast cancer and...

Prof Hope Rugo - University of California San Francisco, San Francisco, USA

Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC ( Prof Hope Rugo - University of California San Francisco, San Francisco, USA )

Challenges in nursing GU cancer patients during COVID-19

Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK

Challenges in nursing GU cancer patients during COVID-19 ( Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK )

Latest developments in the treatment of mRCC

Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald

Latest developments in the treatment of mRCC ( Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald )

Long term response to apalutamide and other updates impacting patients with...

Prof Axel Merseburger and Prof Matthew Smith

Long term response to apalutamide and other updates impacting patients with nmCRPC from ASCO GU 2021 ( Prof Axel Merseburger and Prof Matthew Smith )

More from ecancer